Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Dermoscopy | 11 | 2020 | 346 | 4.32 | Why? |
| Nail Diseases | 4 | 2019 | 142 | 2.33 | Why? |
| Lichen Nitidus | 2 | 2019 | 4 | 1.56 | Why? |
| Platelet-Rich Plasma | 2 | 2019 | 91 | 1.40 | Why? |
| Nails | 2 | 2017 | 143 | 1.21 | Why? |
| Genetic Diseases, X-Linked | 2 | 2018 | 237 | 1.19 | Why? |
| Dermatologists | 3 | 2021 | 435 | 0.90 | Why? |
| Heel | 1 | 2019 | 19 | 0.79 | Why? |
| Eyebrows | 1 | 2018 | 14 | 0.78 | Why? |
| Lichenoid Eruptions | 1 | 2019 | 22 | 0.77 | Why? |
| Hamartoma | 1 | 2019 | 21 | 0.77 | Why? |
| Folliculitis | 1 | 2018 | 12 | 0.76 | Why? |
| Trichloroacetic Acid | 1 | 2018 | 8 | 0.76 | Why? |
| Chemexfoliation | 1 | 2018 | 10 | 0.76 | Why? |
| Striae Distensae | 1 | 2018 | 7 | 0.75 | Why? |
| Transillumination | 1 | 2017 | 9 | 0.74 | Why? |
| Triamcinolone Acetonide | 1 | 2017 | 10 | 0.73 | Why? |
| Punctures | 1 | 2018 | 89 | 0.72 | Why? |
| Epidermal Cyst | 1 | 2017 | 10 | 0.72 | Why? |
| Warts | 1 | 2018 | 59 | 0.72 | Why? |
| Antifibrinolytic Agents | 1 | 2019 | 150 | 0.72 | Why? |
| Tranexamic Acid | 1 | 2019 | 121 | 0.71 | Why? |
| Dermatomycoses | 1 | 2018 | 55 | 0.71 | Why? |
| Software | 2 | 2020 | 2501 | 0.71 | Why? |
| Light | 1 | 2020 | 306 | 0.70 | Why? |
| Ophthalmoscopy | 1 | 2018 | 65 | 0.70 | Why? |
| Publication Bias | 1 | 2019 | 241 | 0.70 | Why? |
| Skin Diseases, Vascular | 1 | 2018 | 69 | 0.68 | Why? |
| Arm | 1 | 2018 | 159 | 0.67 | Why? |
| Acne Vulgaris | 1 | 2019 | 198 | 0.63 | Why? |
| Social Perception | 1 | 2020 | 371 | 0.63 | Why? |
| Skin Diseases | 4 | 2020 | 2509 | 0.61 | Why? |
| Mucous Membrane | 1 | 2018 | 305 | 0.59 | Why? |
| Cholecalciferol | 1 | 2018 | 246 | 0.58 | Why? |
| Erythema | 1 | 2019 | 400 | 0.57 | Why? |
| Dermatology | 3 | 2020 | 1999 | 0.57 | Why? |
| Drainage | 1 | 2017 | 414 | 0.54 | Why? |
| Alopecia | 1 | 2018 | 351 | 0.52 | Why? |
| Hand | 1 | 2018 | 449 | 0.52 | Why? |
| Safety Management | 1 | 2020 | 1093 | 0.45 | Why? |
| Attitude | 1 | 2020 | 1481 | 0.42 | Why? |
| Vitamins | 1 | 2018 | 1208 | 0.39 | Why? |
| Congresses as Topic | 1 | 2019 | 1347 | 0.39 | Why? |
| Skin | 2 | 2019 | 2096 | 0.38 | Why? |
| Injections, Intralesional | 2 | 2018 | 34 | 0.38 | Why? |
| Smartphone | 1 | 2020 | 1840 | 0.37 | Why? |
| Research Personnel | 1 | 2019 | 1037 | 0.37 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2020 | 1380 | 0.37 | Why? |
| Remote Consultation | 2 | 2020 | 2396 | 0.36 | Why? |
| Thorax | 1 | 2018 | 1873 | 0.36 | Why? |
| Equipment Design | 4 | 2019 | 3095 | 0.33 | Why? |
| Eye Diseases | 1 | 2018 | 1150 | 0.32 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.29 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.28 | Why? |
| Sunscreening Agents | 1 | 2020 | 63 | 0.20 | Why? |
| Malassezia | 1 | 2018 | 8 | 0.19 | Why? |
| Neurocutaneous Syndromes | 1 | 2018 | 6 | 0.19 | Why? |
| Foreign-Body Reaction | 1 | 2018 | 8 | 0.19 | Why? |
| Timolol | 1 | 2018 | 11 | 0.19 | Why? |
| Aortic Coarctation | 1 | 2018 | 21 | 0.19 | Why? |
| Administration, Cutaneous | 1 | 2019 | 229 | 0.19 | Why? |
| Eye Abnormalities | 1 | 2018 | 29 | 0.19 | Why? |
| Humans | 33 | 2021 | 930598 | 0.18 | Why? |
| Acitretin | 1 | 2017 | 23 | 0.18 | Why? |
| Suspensions | 1 | 2017 | 63 | 0.18 | Why? |
| Capsules | 1 | 2017 | 140 | 0.17 | Why? |
| Open Access Publishing | 1 | 2019 | 116 | 0.17 | Why? |
| Itraconazole | 1 | 2018 | 135 | 0.17 | Why? |
| Peer Review | 1 | 2019 | 204 | 0.16 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.16 | Why? |
| Product Surveillance, Postmarketing | 1 | 2018 | 189 | 0.16 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.15 | Why? |
| Deception | 1 | 2019 | 225 | 0.15 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.15 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.14 | Why? |
| Adrenergic beta-Antagonists | 1 | 2018 | 465 | 0.14 | Why? |
| Clinical Clerkship | 1 | 2020 | 403 | 0.14 | Why? |
| Eye | 1 | 2019 | 374 | 0.14 | Why? |
| Violence | 1 | 2020 | 534 | 0.14 | Why? |
| Skin Diseases, Viral | 1 | 2020 | 436 | 0.13 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.13 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.13 | Why? |
| Virtual Reality | 1 | 2020 | 640 | 0.12 | Why? |
| Infection Control | 2 | 2020 | 23131 | 0.11 | Why? |
| Cell Phone | 1 | 2019 | 750 | 0.11 | Why? |
| Physician-Patient Relations | 1 | 2020 | 1266 | 0.10 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.09 | Why? |
| Diagnosis, Differential | 2 | 2020 | 7220 | 0.08 | Why? |
| India | 2 | 2020 | 11875 | 0.07 | Why? |
| Clinical Competence | 1 | 2020 | 3263 | 0.07 | Why? |
| Personal Protective Equipment | 2 | 2020 | 15978 | 0.07 | Why? |
| Immunotherapy | 1 | 2018 | 2421 | 0.07 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
| Fear | 1 | 2020 | 3607 | 0.07 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.07 | Why? |
| Machine Learning | 1 | 2020 | 4395 | 0.06 | Why? |
| Occupational Health | 1 | 2020 | 3965 | 0.06 | Why? |
| Psoriasis | 1 | 2017 | 1739 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2019 | 17020 | 0.06 | Why? |
| Internet | 1 | 2021 | 6204 | 0.06 | Why? |
| Treatment Outcome | 3 | 2019 | 51732 | 0.06 | Why? |
| Communication | 1 | 2020 | 5206 | 0.06 | Why? |
| Glucocorticoids | 1 | 2017 | 4431 | 0.06 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.06 | Why? |
| Infant | 3 | 2019 | 30274 | 0.06 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.05 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.05 | Why? |
| Male | 5 | 2020 | 367725 | 0.05 | Why? |
| Child | 2 | 2018 | 70012 | 0.05 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.05 | Why? |
| Drug Liberation | 1 | 2018 | 141 | 0.05 | Why? |
| Masks | 1 | 2020 | 8528 | 0.04 | Why? |
| Solubility | 1 | 2018 | 382 | 0.04 | Why? |
| Administration, Topical | 1 | 2018 | 272 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.04 | Why? |
| Female | 5 | 2020 | 380317 | 0.04 | Why? |
| Water | 1 | 2018 | 765 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.03 | Why? |
| Organizational Innovation | 1 | 2020 | 2468 | 0.03 | Why? |
| Animals | 1 | 2019 | 78931 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.02 | Why? |
| Attitude of Health Personnel | 1 | 2020 | 4741 | 0.01 | Why? |
| Pediatrics | 1 | 2017 | 2969 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Adult | 1 | 2020 | 244371 | 0.00 | Why? |
| Middle Aged | 1 | 2020 | 270681 | 0.00 | Why? |
Jakhar's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(134)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_